Document is current

Combination and sequential treatments for spinal muscular atrophy: First experience with Onasemnogen abeparvovec (Zolgensma®) plus Risdiplam (Everysdi®) in a private hospital in Mexico

Crossref DOI link: https://doi.org/10.30574/ijsra.2025.16.2.2381

Published Online: 2025-08-30

Update policy: https://doi.org/10.30574/ijsra.ourcrossmarkpolicy